A strong performer already, GSK stock is trading up 44% in 2025, yet its stock remains a good bargain. GSK trades for a reasonable P/E ratio of just 13 and is the second-least expensive (by P/E) of …
The Best Healthcare Stock to Hold in Uncertain Times
view original post